Halozyme Therapeutics
HALO
#2303
Rank
NZ$13.72 B
Marketcap
NZ$116.68
Share price
3.44%
Change (1 day)
39.83%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: NZ$13.72 Billion

As of December 2025 Halozyme Therapeutics has a market cap of NZ$13.72 Billion. This makes Halozyme Therapeutics the world's 2303th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$13.72 B26.38%
2024NZ$10.85 B40.64%
2023NZ$7.72 B-36.29%
2022NZ$12.11 B46.21%
2021NZ$8.28 B3.58%
2020NZ$8.00 B122.33%
2019NZ$3.59 B14.02%
2018NZ$3.15 B-22.27%
2017NZ$4.06 B119.88%
2016NZ$1.84 B-43.08%
2015NZ$3.24 B109.56%
2014NZ$1.54 B-25.89%
2013NZ$2.08 B127.26%
2012NZ$0.91 B-27.24%
2011NZ$1.26 B22.37%
2010NZ$1.03 B39.35%
2009NZ$0.74 B-5.72%
2008NZ$0.78 B8.69%
2007NZ$0.72 B-7.93%
2006NZ$0.78 B389.59%
2005NZ$0.16 B5.75%
2004NZ$0.15 B

End of Day market cap according to different sources

On Dec 21st, 2025 the market cap of Halozyme Therapeutics was reported to be:

NZ$13.72 Billion
by Nasdaq info icon info icon
NZ$13.72 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MannKind Corp
MNKD
NZ$3.10 B-77.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.664 T 12,027.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$16.88 B 23.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$248.13 B 1,708.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$203.74 B 1,384.87%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
NZ$861.40 B 6,177.73%๐Ÿ‡บ๐Ÿ‡ธ USA